Correlation Between Ironwood Pharmaceuticals and Pacira BioSciences,

Can any of the company-specific risk be diversified away by investing in both Ironwood Pharmaceuticals and Pacira BioSciences, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ironwood Pharmaceuticals and Pacira BioSciences, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Ironwood Pharmaceuticals and Pacira BioSciences,, you can compare the effects of market volatilities on Ironwood Pharmaceuticals and Pacira BioSciences, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ironwood Pharmaceuticals with a short position of Pacira BioSciences,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ironwood Pharmaceuticals and Pacira BioSciences,.

Diversification Opportunities for Ironwood Pharmaceuticals and Pacira BioSciences,

-0.33

Correlation Coefficient

Ironwood Pharmaceuticals  Pacira BioSciences,

Very good diversification

The 3 months correlation between Ironwood and Pacira is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Ironwood Pharmaceuticals and Pacira BioSciences, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pacira BioSciences, and Ironwood Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ironwood Pharmaceuticals are associated (or correlated) with Pacira BioSciences,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pacira BioSciences, has no effect on the direction of Ironwood Pharmaceuticals i.e., Ironwood Pharmaceuticals and Pacira BioSciences, go up and down completely randomly.

Pair Corralation between Ironwood Pharmaceuticals and Pacira BioSciences,

Given the investment horizon of 90 days Ironwood Pharmaceuticals is expected to generate 3.52 times more return on investment than Pacira BioSciences,. However, Ironwood Pharmaceuticals is 3.52 times more volatile than Pacira BioSciences,. It trades about 0.02 of its potential returns per unit of risk. Pacira BioSciences, is currently generating about -0.06 per unit of risk. If you would invest  79.00  in Ironwood Pharmaceuticals on May 7, 2025 and sell it today you would lose (4.00) from holding Ironwood Pharmaceuticals or give up 5.06% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Ironwood Pharmaceuticals  vs.  Pacira BioSciences,

Ironwood Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Ironwood Pharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain basic indicators, Ironwood Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in September 2025.

Pacira BioSciences,

Risk-Adjusted Performance

Very Weak

Over the last 90 days Pacira BioSciences, has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest inconsistent performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Pair Trading with Ironwood Pharmaceuticals and Pacira BioSciences,

The main advantage of trading using opposite Ironwood Pharmaceuticals and Pacira BioSciences, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ironwood Pharmaceuticals position performs unexpectedly, Pacira BioSciences, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pacira BioSciences, will offset losses from the drop in Pacira BioSciences,'s long position.

The idea behind Ironwood Pharmaceuticals and Pacira BioSciences, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.